CJC-1295 & Ipamorelin Blend (10mg)

Advanced Growth Hormone Research Blend

CJC-1295 Ipamorelin Blend Peptide is a premium research formulation combining two widely studied growth hormone secretagogues. Researchers have investigated this peptide blend for its potential role in supporting growth hormone release, IGF-1 expression, cellular signaling, and metabolic research applications.

The combination of CJC-1295 and Ipamorelin is frequently examined for its complementary mechanisms of action. While CJC-1295 is studied for its long-lasting growth hormone-releasing hormone (GHRH) activity, Ipamorelin is recognized for its selective interaction with growth hormone secretagogue receptors (GHS-R1a), making this blend a valuable tool for scientific research.

Key Research Benefits

• Combines CJC-1295 and Ipamorelin in a single research blend
• Studied for growth hormone and IGF-1 pathway research
• Investigated for cellular recovery and regeneration mechanisms
• Explored for metabolic and endocrine function research
• Examined for nitrogen balance and lean tissue studies
• Popular in growth hormone secretagogue research

What is CJC-1295?

CJC-1295 is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH). Scientific studies suggest it may support prolonged stimulation of growth hormone release by interacting with GHRH receptors in the pituitary gland.

Researchers have investigated CJC-1295 for:

• Growth hormone secretion
• IGF-1 production
• Cellular signaling pathways
• Endocrine system research
• Long-acting peptide applications

What is Ipamorelin?

Ipamorelin is a selective growth hormone secretagogue that interacts with the GHS-R1a receptor. Unlike many other growth hormone-releasing peptides, it has been studied for its receptor selectivity and targeted growth hormone research potential.

Research involving ipamorelin has explored the following:

• Growth hormone release
• Cellular metabolism
• Nitrogen balance
• Pituitary signaling pathways
• Endocrine function research

Why Researchers Use CJC-1295 & Ipamorelin Together

The CJC-1295 Ipamorelin Blend Peptide is frequently studied because the two compounds may provide complementary activity. Ipamorelin may contribute to an initial growth hormone response, while CJC-1295 is investigated for its extended duration of action.

This synergistic approach has made the blend a popular subject of research involving:

• Growth hormone regulation
• IGF-1 expression
• Cellular repair processes
• Recovery and regeneration studies
• Metabolic pathway analysis
• Neuroendocrine research

Product Specifications

Research Compound: CJC-1295 & Ipamorelin Blend

Category: Growth Hormone Secretagogue Research Peptides

Research Use: Laboratory and scientific research only

Storage Recommendations: Store in a cool, dry place away from heat and direct sunlight.

Research Use Only

This product is intended strictly for laboratory research purposes. It is not intended for human consumption, medical use, diagnosis, treatment, or prevention of any disease. All research should be conducted by qualified professionals following applicable regulations and laboratory standards.